(78 days)
Not Found
No
The document describes physical surgical instruments (femoral head trials) made of PPSU and barium sulfate, used to assist in hip implant surgery. There is no mention of software, algorithms, data processing, or any technology that would suggest the use of AI or ML. The description focuses solely on the physical characteristics and intended use of the instruments.
No.
The device is an accessory device (femoral head trials) used to assist in the implantation of hip systems, which are therapeutic devices. However, the trials themselves are instruments for implantation, not therapeutic devices.
No
The device is described as an "accessory device" and "instruments" intended "to assist in the implantation of Smith & Nephew Hip Systems". It is not used for diagnosis.
No
The device description explicitly states the device is manufactured from polyphenylsulfone (PPSU) with barium sulfate and colorants, indicating it is a physical instrument, not software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description and Intended Use: The text clearly describes the devices as "accessory devices" and "instruments" used to "assist in the implantation of Smith & Nephew Hip Systems." They are physical tools used during surgery to help place hip implants.
- Lack of Biological Sample Analysis: There is no mention of the device interacting with or analyzing any biological samples from the patient. Its function is purely mechanical, aiding in the surgical procedure.
Therefore, the Smith & Nephew Global Femoral Head Trials and associated instruments are surgical instruments, not in vitro diagnostic devices.
N/A
Intended Use / Indications for Use
Smith & Nephew Global Femoral Head Trials are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew Hip Systems in their cleared Indications for Use as provided below.
Smith & Nephew Uncemented Femoral Stem Instruments are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew Uncemented Hip Systems and their cleared Indications for Use.
Uncemented Femoral Stems are indicated for uncemented use in individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma, inflammatory joint disease such as rheumatoid arthritis, or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular necrosis; traumatic arthritis; slipped capital epiphysis; fused hip; fracture of the pelvis; diastrophic variant; old, remote osteomyelitis with an extended drainage-free period; nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; femoral osteotomy, or Girdlestone resection; fracture dislocation of the hip; and correction of deformity.
Smith & Nephew Cemented Femoral Stem Instruments are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew Cemented Hip Systems and their cleared Indications for Use.
Cemented Femoral Stems are indicated for cemented use in individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma, inflammatory joint disease such as rheumatoid arthritis, or noninflammatory degenerative ioint disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular necrosis; traumatic arthritis; slipped capital epiphysis; fused hip; fracture of the pelvis: diastrophic variant; old, remote osteomyelitis with an extended drainage-free period; nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; femoral osteotomy, or Girdlestone resection; fracture dislocation of the hip; and correction of deformity.
Smith & Nephew PLUS Femoral Stem Instruments are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew PLUS Hip Systems and their cleared Indications for Use.
Smith & Nephew Inc PLUS Femoral Stems are indicated for:
- The SL-PLUS Stem Primary is intended for treating patients who are candidates for total hip arthroplasty because the natural femoral head and neck has been subject to disease or trauma. The SL-PLUS Stem is intended for advanced hip joint wear due to degenerative, posttraumatic or rheumatoid arthritis; fracture or avascular necrosis of the femoral head.
- The SLR-PLUS STEM, a revision component, is also available to replace previously failed femoral him arthroplasties. Both components can be used with or without cement. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.
- The SL-PLUS Lateralized Stem is intended for varus femur forms and trumpet shape of the proximal femur (champagne flute). These stems are for uncemented use only. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.
- The SL-PLUS MIA Stem is indicated for individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant.
- The POLARSTEM Standard and Lateral Femoral Stems are indicated for: advanced degeneration of the hip joint as a result of degenerative, post-traumatic or rheumatoid arthritis, fracture or avascular necrosis of the femoral head, failure of previous hip surgery: joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement, all forms of osteoarthritis, patients with hips at risk of dislocation, and femoral neck fracture or proximal fracture to hip joint.
Product codes (comma separated list FDA assigned to the subject device)
LZO, KWY, LWJ, LPH, JDI, MEH, MBL
Device Description
Per U.S Food and Drug Administration (FDA) regulation, device-specific instruments are accessory devices and take on the classification of the device(s) with which they are used. Instruments that are designed to assist in the implantation of Class II Smith & Nephew Hip Systems are classified as Class II devices and are subject to premarket notifications and regulations.
The subjects of this 510 k) are the Smith & Nephew Global Femoral Head Trials. The femoral head trials are instruments used to assist in the implantation of cleared Smith & Nephew hip systems.
The subject devices are similar to existing femoral head trials currently being used by surgeons when implanting femoral hip systems. The trials are manufactured from polyphenylsulfone (PPSU) with up to 10% of the radiopacifier barium sulfate. In addition, colorants are blended into the PPSU resin to allow for differentiation between the various sizes. The same materials are used in the manufacturing of existing hip system trials.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip joint, femoral head, proximal femur
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis.
(a)
Identification. A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.(b)
Classification. Class II.
0
K132435 page 1 of 4
> We are smith&nephew
Submitted by:
Date of Summary:
Contact Person and Address:
Name of Device:
Common Name:
Device Classification Name and Reference:
Smith & Nephew, Inc. Advanced Surgical Devices Division 1450 East Brooks Road Memphis, Tennessee 38116
October 17, 2013
Megan Fessenden
Regulatory Affairs Specialist
T 901-399-1104 F 901-721-2583
OCT 22 2013
Smith & Nephew, Inc. Global Femoral Head Trials
Orthopaedic Surgical Instrumentation
21 CFR 888.3350 Hip joint metal/polymer semi-constrained cemented prosthesis
21 CFR 888.3353 Hip joint metal/ceramic/polymer semiconstrained cemented or nonporous uncemented prosthesis 21 CFR 888,3358 Hip joint metal/polymer metal semiconstrained porous-coated uncemented prosthesis 21 CFR 888.3360 Hip joint femoral (hemi-hip) metallic cemented or uncemented prosthesis 21 CFR 888.3390 Hip joint femoral (hemi-hip) metal/polymer
cemented or uncemented prosthesis
| Device Class: | Class II |
|---|---|
| Panel Code: | Orthopaedics/87 |
| Product Code: | LZO, KWY, LWJ, LPH, JDI, MEH, MBL |
Device Description
Per U.S Food and Drug Administration (FDA) regulation, device-specific instruments are accessory devices and take on the classification of the device(s) with which they are used. Instruments that are designed to assist in the implantation of Class II Smith & Nephew Hip Systems are classified as Class II devices and are subject to premarket notifications and regulations.
The subjects of this 510|k) are the Smith & Nephew Global Femoral Head Trials. The femoral head trials are instruments used to assist in the implantation of cleared Smith & Nephew hip systems.
Intended Use
Smith & Nephew Global Femoral Head Trials are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew Hip Systems in their cleared Indications for Use as provided below.
1
K132435 page 2 of 4
Smith & Nephew Uncemented Femoral Stems
Smith & Nephew Uncemented Femoral Stem Instruments are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew Uncemented Hip Systems and their cleared Indications for Use.
Uncemented Femoral Stems are indicated for uncemented use in individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma, inflammatory joint disease such as rheumatoid arthritis, or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular necrosis; traumatic arthritis; slipped capital epiphysis; fused hip; fracture of the pelvis; diastrophic variant; old, remote osteomyelitis with an extended drainage-free period; nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; femoral osteotomy, or Girdlestone resection; fracture dislocation of the hip; and correction of deformity.
Smith & Nephew Cemented Femoral Stems
Smith & Nephew Cemented Femoral Stem Instruments are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew Cemented Hip Systems and their cleared Indications for Use.
Cemented Femoral Stems are indicated for cemented use in individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma, inflammatory joint disease such as rheumatoid arthritis, or noninflammatory degenerative ioint disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular necrosis; traumatic arthritis; slipped capital epiphysis; fused hip; fracture of the pelvis: diastrophic variant; old, remote osteomyelitis with an extended drainage-free period; nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; femoral osteotomy, or Girdlestone resection; fracture dislocation of the hip; and correction of deformity.
Smith & Nephew Inc. PLUS Femoral Stems
Smith & Nephew PLUS Femoral Stem Instruments are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew PLUS Hip Systems and their cleared Indications for Use.
Smith & Nephew Inc PLUS Femoral Stems are indicated for:
- The SL-PLUS Stem Primary is intended for treating patients who are candidates for . total hip arthroplasty because the natural femoral head and neck has been subject to disease or trauma. The SL-PLUS Stem is intended for advanced hip joint wear due to
Confidential 3
Confidential
2
degenerative, posttraumatic or rheumatoid arthritis; fracture or avascular necrosis of the femoral head.
- The SLR-PLUS STEM, a revision component, is also available to replace previously . failed femoral him arthroplasties. Both components can be used with or without cement. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.
- The SL-PLUS Lateralized Stem is intended for varus femur forms and trumpet shape . of the proximal femur (champagne flute). These stems are for uncemented use only. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.
- The SL-PLUS MIA Stem is indicated for individuals undergoing primary and revision . surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant.
- . The POLARSTEM Standard and Lateral Femoral Stems are indicated for: advanced degeneration of the hip joint as a result of degenerative, post-traumatic or rheumatoid arthritis, fracture or avascular necrosis of the femoral head, failure of previous hip surgery: joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement, all forms of osteoarthritis, patients with hips at risk of dislocation, and femoral neck fracture or proximal fracture to hip joint.
Technological Characteristics
The subject devices are similar to existing femoral head trials currently being used by surgeons when implanting femoral hip systems. The trials are manufactured from polyphenylsulfone (PPSU) with up to 10% of the radiopacifier barium sulfate. In addition, colorants are blended into the PPSU resin to allow for differentiation between the various sizes. The same materials are used in the manufacturing of existing hip system trials.
Substantial Equivalence Information
When compared to the previously cleared device-specific instruments listed in Table 2, the proposed instruments utilize the same raw materials, manufacturing processes, and sterilization methods (where applicable). It should also be noted that the nature of body contact is the same as found with the predicate devices that have been identified in this premarket notification.
| Manufacturer | Description | Submission
Number | Clearance Date |
|----------------|------------------------|----------------------|----------------|
| Smith & Nephew | Radiopaque Trial Necks | K113039 | 10/5/2012 |
Table 2: Substantially Equivalent Predicates to the Global Femoral Head Trials
3
K132435 page 4 of 4
Conclusion
This Traditional 510(k) Premarket Notification is being submitted to request clearance for the Global Femoral Head Trials. Based upon the technological and material similarities, the Global Formeral Frontially equivalent to the predicate devices identified in this premarket notification.
4
Image /page/4/Picture/0 description: The image shows the text "DEPARTMENT OF HEALTH & HUMAN SERVICES" in all caps. The text is in a bold, sans-serif font. The text is centered horizontally and vertically in the image. The background of the image is white.
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus, which is a symbol often associated with medicine and healthcare. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the caduceus. The logo is presented in black and white.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 22, 2013
Smith & Nephew, Incorporated Ms. Megan Fessenden Regulatory Affairs Specialist 7135 Goodlett Farms Parkway Cordova, Tennessee 38016
Re: K132435
Trade/Device Name: Global Femoral Head Trials for use with Smith & Nephew, Inc. Uncemented, Cemented and PLUS Femoral Stems Regulation Number: 21 CFR 888.3353 Regulation Name: Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Regulatory Class: Class II Product Code: LZO, KWY, LWJ, LPH, JDI, MEH, MBL Dated: August 26, 2013 Received: August 28, 2013
Dear Ms. Fessenden:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
5
Page 2 - Ms. Megan Fessenden
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers. International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office
of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Erin 原Keith
for
Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
510(k) Number (if known): K 132435 page 1 of 4
Device Name: Global Femoral Head Trials for use with Smith & Nephew Inc. Uncemented Femoral Stems
Indications for Use:
Smith & Nephew Uncemented Femoral Stem Instruments are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew Uncemented Hip Systems and their cleared Indications for Use.
Uncemented Femoral Stems are indicated for uncemented use in individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma, inflammatory joint disease such as rheumatoid arthritis, or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular necrosis; traumatic arthritis; slipped capital epiphysis; fused hip; fracture of the pelvis; diastrophic variant; old, remote osteomyelitis with an extended drainage-free period; nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; femoral osteotomy, or Girdlestone resection; fracture dislocation of the hip; and correction of deformity.
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Elizabeth L. Frank -S
র্তা - Page Page -
7
Giobal Femoral Head Trials Indications for Use
510(k) Number (if known): K132435 page 2 of 4
Device Name: Global Femoral Head Trials for use with Smith & Nephew, Inc. Cemented Femoral Stems
Indications for Use:
Smith & Nephew Cemented Femoral Stem Instruments are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew Cemented Hip Systems and their cleared Indications for Use.
Cemented Femoral Stems are indicated for cemented use in individuals undergoing primary and revision surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma, inflammatory joint disease such as rheumatoid arthritis, or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses such as osteoarthritis; avascular necrosis; traumatic arthritis; slipped capital epiphysis; fused hip; fracture of the pelvis; diastrophic variant; old, remote osteomyelitis with an extended drainage-free period; nonunion, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques; femoral osteotomy, or Girdlestone resection; fracture dislocation of the hip; and correction of deformity.
x AND/OR Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use . (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Elizabeth L. Frank -S
Page _________________________________________________________________________________________________________________________________________________________________________
8
Global Femoral Head Tria Indications for Us
510(k) Number (if known):
K132435 page 3 of 4
Device Name: Global Femoral Head Trials for use with Smith & Nephew Inc PLUS Femoral Stems
Indications for Use:
Smith & Nephew PLUS Femoral Stem Instruments are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew PLUS Hip Systems and their cleared Indications for Use.
Smith & Nephew Inc PLUS Femoral Stems are indicated for:
- The SL-PLUS Stem Primary is intended for treating patients who are candidates for total . hip arthroplasty because the natural femoral head and neck has been subject to disease or trauma. The SL-PLUS Stem is intended for advanced hip joint wear due to degenerative, posttraumatic or rheumatoid arthritis; fracture or avascular necrosis of the femoral head.
- The SLR-PLUS STEM, a revision component, is also available to replace previously failed . femoral him arthroplasties. Both components can be used with or without cement. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.
- The SL-PLUS Lateralized Stem is intended for varus femur forms and trumpet shape of the . proximal femur (champagne flute). These stems are for uncemented use only. These devices are intended to aid the surgeon in relieving the patient of hip pain and restoring hip motion.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page _ ol
Elizabeth L. Frank -S
9
Global Femoral Head Trials Indications for Use
510(k) Number (if known): K132435 page 4 of 4
Device Name: Global Femoral Head Trials for use with Smith & Nephew Inc PLUS Femoral Stems
Indications for Use (continued):
- The SL-PLUS MIA Stem is indicated for individuals undergoing primary and revision . surgery where other treatments or devices have failed in rehabilitating hips damaged as a result of trauma or noninflammatory degenerative joint disease (NIDJD) or any of its composite diagnoses of osteoarthritis, avascular necrosis, traumatic arthritis, slipped capital epiphysis, fused hip, fracture of the pelvis, and diastrophic variant.
- The POLARSTEM Standard and Lateral Femoral Stems are indicated for: advanced . degeneration of the hip joint as a result of degenerative, post-traumatic or rheumatoid arthritis, fracture or avascular necrosis of the femoral head, failure of previous hip surgery: joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement, all forms of osteoarthritis, patients with hips at risk of dislocation, and femoral neck fracture or proximal fracture to hip joint.
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)